{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:03:10Z","timestamp":1791154990109,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1584,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/jid.2011.123","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T08:37:14Z","timestamp":1305794234000},"page":"1660-1667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["A GPR40 Agonist GW9508 Suppresses CCL5, CCL17, and CXCL10 Induction in Keratinocytes and Attenuates Cutaneous Immune Inflammation"],"prefix":"10.1016","volume":"131","author":[{"given":"Tomoko","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuh","family":"Narumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.123_bb0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2011.123_bb0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0706770","article-title":"Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules","volume":"148","author":"Briscoe","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1038\/jid.2011.123_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/039463200702000303","article-title":"Anti-chemokine therapy for inflammatory diseases","volume":"20","author":"Castellani","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1038\/jid.2011.123_bb0025","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1194\/jlr.R700013-JLR200","article-title":"Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis","volume":"48","author":"Feingold","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1038\/jid.2011.123_bb0030","first-page":"191","article-title":"The role of chemokines in inflammatory skin diseases","volume":"44","author":"Girolomoni","year":"2004","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1038\/jid.2011.123_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat Med"},{"key":"10.1038\/jid.2011.123_bb0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaci.2009.04.029","article-title":"Prostaglandin E2-EP3 signaling suppresses skin inflammation in murine contact hypersensitivity","volume":"124","author":"Honda","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2011.123_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2006.07.019","article-title":"Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone","volume":"546","author":"Inagaki","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/jid.2011.123_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1038\/jid.2011.123_bb0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ni943","article-title":"Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity","volume":"4","author":"Kabashima","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2011.123_bb0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2011.123_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/jid.2011.123_bb0070","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","article-title":"Attenuation of allergic contact dermatitis through the endocannabinoid system","volume":"316","author":"Karsak","year":"2007","journal-title":"Science"},{"key":"10.1038\/jid.2011.123_bb0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajhg.2009.06.021","article-title":"Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome","volume":"85","author":"Klar","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1038\/jid.2011.123_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni1188","article-title":"Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3","volume":"6","author":"Kunikata","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2011.123_bb0085","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.4049\/jimmunol.0901856","article-title":"Apurinic\/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses","volume":"183","author":"Lee","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/jid.2011.123_bb0090","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.4049\/jimmunol.0990015","article-title":"The unexpected pleiotropic activities of RANTES","volume":"182","author":"Levy","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/jid.2011.123_bb0095","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.2353\/ajpath.2010.081059","article-title":"CXCR3\/ligands are significantly involved in the tumorigenesis of basal cell carcinomas","volume":"176","author":"Lo","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2011.123_bb0100","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/jid.2008.5","article-title":"Cutaneous hypersensitivities to hapten are controlled by IFN-\u03b3-upregulated keratinocyte Th1 chemokines and IFN-\u03b3-downregulated langerhans cell Th2 chemokines","volume":"128","author":"Mori","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.123_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/intimm\/dxg028","article-title":"IL-1-induced tumor necrosis factor-\u03b1 elicits inflammatory cell infiltration in the skin by inducing IFN-\u03b3-inducible protein 10 in the elicitation phase of the contact hypersensitivity response","volume":"15","author":"Nakae","year":"2003","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2011.123_bb0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbi.2007.03.008","article-title":"Autonomic innervation and regulation of the immune system (1987\u20132007)","volume":"21","author":"Nance","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1038\/jid.2011.123_bb0115","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"key":"10.1038\/jid.2011.123_bb0120","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.164.3.1612","article-title":"Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES","volume":"164","author":"Nickel","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/jid.2011.123_bb0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1038\/jid.2011.123_bb0130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2133.2005.06474.x","article-title":"Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis","volume":"152","author":"Park","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.123_bb0135","first-page":"125","article-title":"The contribution of keratinocytes to the pathogenesis of atopic dermatitis","volume":"16","author":"Pastore","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1038\/jid.2011.123_bb0140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2011.123_bb0145","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.0901206106","article-title":"The cytokine interleukin-33 mediates anaphylactic shock","volume":"106","author":"Pushparaj","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.123_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2007.01.007","article-title":"Tipping the gatekeeper: S1P regulation of endothelial barrier function","volume":"28","author":"Rosen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1038\/jid.2011.123_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases","volume":"43","author":"Saeki","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2011.123_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1744-313X.2006.00635.x","article-title":"Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis","volume":"33","author":"Tanaka","year":"2006","journal-title":"Int J Immunogenet"},{"key":"10.1038\/jid.2011.123_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0923-1811(02)00138-X","article-title":"Lack of evidence for TARC\/CCL17 production by normal human keratinocytes in vitro","volume":"31","author":"Tsuda","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2011.123_bb0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2008.09.044","article-title":"Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis","volume":"123","author":"Ueta","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2011.123_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0923-1811(02)00149-4","article-title":"Both IL-4 and IL-13 inhibit the TNF-\u03b1 and IFN-\u03b3 enhanced MDC production in a human keratinocyte cell line, HaCaT cells","volume":"31","author":"Xiao","year":"2003","journal-title":"J Dermatol Sci"},{"issue":"Suppl 1","key":"10.1038\/jid.2011.123_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000237713","article-title":"Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes","volume":"114","author":"Yamada","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1038\/jid.2011.123_bb0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.1968","article-title":"Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion","volume":"15","author":"Yao","year":"2009","journal-title":"Nat Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15353641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15353641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:57:35Z","timestamp":1743940655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15353641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0022202X15353641"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.123","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A GPR40 Agonist GW9508 Suppresses CCL5, CCL17, and CXCL10 Induction in Keratinocytes and Attenuates Cutaneous Immune Inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}